Helsinn
Lugano, CH · Founded 1976 · 343 employees on LinkedIn · 1 known investors
Find your way into Helsinn
174 people in our graph share verified history with the Helsinn team — schools, employers, funds. One of them is your warm intro.
Giuseppe Zoccounlockedknows Riccardo Braglia · together at Università Bocconi (overlapped)
knows the team · via Swiss American Chamber of Commerce
×2knows the team · via Harvard Medical School
×2knows the team · via Windham Venture Partners
×6knows the team · via Temple University
Helsinn is a global pharmaceutical company that develops and distributes supportive care medications for patients with cancer and chronic diseases. The company operates through a combination of direct sales in the United States and commercial partnerships internationally.
Founders & leadership
RB
Riccardo BragliainChairman and CEO at HelsinnRiccardo Braglia is CEO and Chairman of Helsinn Group, a pharmaceutical company focused on late-stage licensing and distribution of supportive care medications for cancer and chronic disease patients across 140 countries. He also serves as Board Member for 3B Future Health Fund and Chairman of HAS Healthcare Advanced Synthesis/Cerbios Pharma.
Investors · 1
In the news
Frequently asked questions
- What does Helsinn do?
- Helsinn is a global pharmaceutical company that develops and distributes supportive care medications for patients with cancer and chronic diseases. The company operates through a combination of direct sales in the United States and commercial partnerships internationally.
- Who are Helsinn's investors?
- Helsinn's investors include Oberland Capital.
- Where is Helsinn headquartered?
- Helsinn is headquartered in Lugano, CH.